Manulife (Manufacturers Life Insurance)’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $594K | Buy |
34,020
+2,469
| +8% | +$43.1K | ﹤0.01% | 2089 |
|
|
2025
Q1 | $397K | Buy |
31,551
+12,025
| +62% | +$151K | ﹤0.01% | 2246 |
|
|
2024
Q4 | $206K | Sell |
19,526
-27,328
| -58% | -$288K | ﹤0.01% | 2612 |
|
|
2024
Q3 | $679K | Buy |
46,854
+25,658
| +121% | +$372K | ﹤0.01% | 2120 |
|
|
2024
Q2 | $180K | Buy |
+21,196
| New | +$180K | ﹤0.01% | 2641 |
|
|
2021
Q4 | – | Sell |
-13,766
| Closed | -$137K | – | 3172 |
|
|
2021
Q3 | $137K | Buy |
13,766
+6,258
| +83% | +$62.3K | ﹤0.01% | 3077 |
|
|
2021
Q2 | $232K | Buy |
7,508
+490
| +7% | +$15.1K | ﹤0.01% | 3002 |
|
|
2021
Q1 | $306K | Buy |
+7,018
| New | +$306K | ﹤0.01% | 2612 |
|